MBRX (Moleculin Biotech) General and Admin. Expense: $9.13 Mil (TTM As of Mar. 2026)

What is Moleculin Biotech General and Admin. Expense?

Moleculin Biotech MBRX +9.00% 30 General and Admin. Expense is $9.13 Mil as of Mar. 2026. GuruFocus rates MBRX with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Moleculin Biotech's General and Admin. Expense for the three months ended in Mar. 2026 was $2.49 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $9.13 Mil.

Moleculin Biotech General and Admin. Expense Related Terms

Moleculin Biotech General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Moleculin Biotech's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moleculin Biotech General and Admin. Expense Chart

Moleculin Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

General and Admin. Expense

Get a 7-Day Free Trial

8.39

11.54

10.02

8.79

9.12

Moleculin Biotech Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
General and Admin. Expense	Get a 7-Day Free Trial															2.48	2.09	2.15	2.41	2.49

30GF Score

Moleculin Biotech Inc MBRX

General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Moleculin Biotech General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.13 Mil.

Frequently Asked Questions Learn more about General and Admin. Expense →

What does a General and Admin. Expense of $9.13 Mil mean?

Moleculin Biotech (MBRX) has a General and Admin. Expense of $9.13 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Moleculin Biotech and its competitors.

Is Moleculin Biotech's General and Admin. Expense too high?

Moleculin Biotech's current General and Admin. Expense is $9.13 Mil. Overall, Moleculin Biotech has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.

How does Moleculin Biotech's General and Admin. Expense compare to ICU and LEXX?

Moleculin Biotech's General and Admin. Expense of $9.13 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good General and Admin. Expense for a Biotechnology company?

A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high General and Admin. Expense mean?

A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Moleculin Biotech and its competitors. Moleculin Biotech's current General and Admin. Expense is $9.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Moleculin Biotech stock overvalued right now?

Moleculin Biotech (MBRX) has a current General and Admin. Expense of $9.13 Mil. The current General and Admin. Expense is $9.13 Mil. Moleculin Biotech's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is General and Admin. Expense calculated?

General and Admin. Expense is calculated from a company's financial statements. For Moleculin Biotech (MBRX), the current General and Admin. Expense is $9.13 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Moleculin Biotech Business Description

Industry Healthcare Biotechnology

Comparable Companies ICU LEXX INTI MTVA CVKD HCWB OSRH COCP HOOK LNAI VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 0K2H:UK

Address 5300 Memorial Drive, Suite 950, Houston, TX, USA, 77007

Website https://www.moleculin.com

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

30GF Score

Get the complete analysis for MBRX

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.26

Price

View MBRX Analysis

See General and Admin. Expense data for all stocks →